Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study: British Journal of Haematology

for Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA), E. Lucchini, F. Palandri, S. Volpetti, N. Vianelli, G. Auteri, E. Rossi, A. Patriarca, G. Carli, W. Barcellini, M. Celli, U. Consoli, F. Valeri, C. Santoro, E. Crea, M. Vignetti, F. Paoloni, C.L. Gigliotti, E. Boggio, U. DianzaniI. Giardini, M. Carpenedo, F. Rodeghiero, R. Fanin, F. Zaja

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)386-396
Number of pages11
JournalBr. J. Haematol.
Issue number2
Publication statusPublished - 2021


  • eltrombopag
  • ITP
  • SROT
  • sustained remission off-treatment
  • tapering

Cite this